勘误：甲胎蛋白检测对肝硬化患者肝细胞癌监测有益。 - Suppr

Corrigendum: Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.

作者信息

Chang Te-Sheng, Wu Yu-Chih, Tung Shui-Yi, Wei Kuo-Liang, Hsieh Yung-Yu, Huang Hao-Chun, Chen Wei-Ming, Shen Chien-Heng, Lu Chang-Hsien, Wu Cheng-Shyong, Tsai Ying-Huang, Huang Yen-Hua

出版信息

Am J Gastroenterol. 2016 Nov;111(11):1668. doi: 10.1038/ajg.2016.426.

DOI:10.1038/ajg.2016.426

PMID:27808145

Abstract

摘要

相似文献

Corrigendum: Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.勘误：甲胎蛋白检测对肝硬化患者肝细胞癌监测有益。

Am J Gastroenterol. 2016 Nov;111(11):1668. doi: 10.1038/ajg.2016.426.

Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.基于甲胎蛋白谱改变的肝细胞癌早期识别。

N Engl J Med. 1993 Jun 24;328(25):1802-6. doi: 10.1056/NEJM199306243282502.

Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.甲胎蛋白的岩藻糖基化指数，可能有助于早期识别肝硬化患者的肝细胞癌。

Hepatology. 1993 Jan;17(1):50-2.

The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.肝硬化患者中用于诊断肝细胞癌的甲胎蛋白水平进行性升高。

BMC Cancer. 2007 Feb 8;7:28. doi: 10.1186/1471-2407-7-28.

Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.甲胎蛋白检测对肝硬化患者肝细胞癌监测有益。

Am J Gastroenterol. 2015 Jun;110(6):836-44; quiz 845. doi: 10.1038/ajg.2015.100. Epub 2015 Apr 14.

Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.甲胎蛋白在代偿性肝硬化监测中发现的小肝细胞癌中无预后作用。

Hepatology. 2012 Oct;56(4):1371-9. doi: 10.1002/hep.25814.

Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.肝硬化患者肝细胞癌检测前血清甲胎蛋白的系列变化

Hepatogastroenterology. 1993 Aug;40(4):347-51.

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.对肝硬化患者进行甲胎蛋白的前瞻性研究，以监测肝细胞癌的发生发展。

Hepatology. 1994 Jan;19(1):61-6.

Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.肿瘤标志物甲胎蛋白（AFP）和异常凝血酶原（PIVKA-II）在中国肝细胞癌患者中的诊断效能

Tumour Biol. 2017 Jun;39(6):1010428317705763. doi: 10.1177/1010428317705763.

Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.肝细胞癌的临床病理特征及危险因素：来自土耳其南部一个中心的结果

Turk J Gastroenterol. 2003 Jun;14(2):85-90.

引用本文的文献

The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.甲胎蛋白（AFP）诊断肝细胞癌的界值：系统评价和荟萃分析。

PLoS One. 2020 Feb 13;15(2):e0228857. doi: 10.1371/journal.pone.0228857. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Corrigendum: Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献